• Users Online: 276
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2020| July-December  | Volume 8 | Issue 2  
    Online since September 10, 2020

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
Recent changes in guidelines on programmatic management of drug resistant tuberculosis in India 2019: a paradigm shift in tuberculosis control
Arunabha Datta Chaudhuri
July-December 2020, 8(2):53-63
The new version of guidelines of programmatic management of drug resistant tuberculosis in India 2019 by Revised National Tuberculosis Control Programme, Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhawan, New Delhi, integrates use of the shorter MDR TB regimen and all oral longer MDR TB regimen with new drugs under RNTCP with opportunity to modify the regimen based on DST results. There are mammoth and comprehensive changes in the guidelines on programmatic management of drug resistant tuberculosis in India 2019.
  3 28,005 2,713
Hypoxemia and oxygen therapy
A. G Ghoshal
July-December 2020, 8(2):42-47
Oxygen is a drug prescribed and administered for specific indications with different pathophysiological mechanism. Oxygen is administered to treat hypoxia not dyspnea. Furthermore, the management of hypoxia in patients with COVID-19 demands separate attention.
  2 4,635 512
Parvo virus infection − an unusual cause of pleural efusion in an immunocompetent patient
Arjun Khanna
July-December 2020, 8(2):99-101
Pleural and pulmonary manifestations of Parvo virus infection are exceedingly rare. Here, we describe an immunocompetent patient with Parvo virus infection who presented with lymphocytic, exudative effusion. Though, this presentation is rare, it may be looked for, if a patient presents with rash and pleural effusion.
  - 1,693 121
Solitary pulmonary nodule − Pulmonary hamartoma
Pooja Khari, Shalini Mullick, Devesh Chauhan
July-December 2020, 8(2):102-105
Pulmonary hamartomas are rare, benign tumours of lung and are composed of an abnormal mixture of epithelial and mesenchymal elements. They usually present as single, round nodules with distinct boundaries and are mostly asymptomatic. We present a case of 45 years old female who presented with cough, chest pain and dyspnea with few episodes of hemoptysis. Computed tomography (CT) scan of thorax showed a well-defined non enhancing mass lesion measuring 4 × 3.2 cm seen in the left lower lobe. Wedge resection was done. Histopathological examination confirmed the diagnosis of pulmonary hamartoma.
  - 1,651 145
A case of chronic cavitory pulmonary aspergillosis, a rare entity
Sibes Kumar Das, Soumyadeep Ghosh, Gopal Sasmal
July-December 2020, 8(2):106-109
Aspergillus species cause a wide spectrum of pulmonary disease including allergic, saprophytic, semi-invasive and invasive aspergillosis. Host immune system is the major determinant of the pattern of illness in human beings. Several chronic forms of Aspergillus infections have been described which include chronic cavitary pulmonary aspergillosis (CCPA), chronic fibrotic pulmonary aspergillosis (CFPA) and chronic necrotizing pulmonary aspergillosis (CNPA). Chronic cavitary pulmonary aspergillosis usually runs a progressive course, affects apparently immunocompetent individuals with a pre-existing lung disease. Diagnosis depends on presence of constitutional and pulmonary symptoms, suggestive radiological changes and microbiological or serological evidence of Aspergillus infection. We hereby present a case of 28 years immunocompetent male who had prior history of pulmonary tuberculosis and was subsequently diagnosed as chronic cavitary pulmonary aspergillosis.
  - 1,533 129
Corrosive esophageal injury caused by impacted button battery
Charulatha Ravindran, Sripriya R., Gobinath Jayaraman
July-December 2020, 8(2):110-111
  - 1,204 86
Our experience of thoracic surgery during COVID19 pandemic
Amitabha Chakrabarti, Manujesh Bandyopadhyay
July-December 2020, 8(2):64-68
COVID19 pandemic has badly affected thoracic surgical services. In this difficult time Thoracic surgeons all over the world are boldly managing thoracic malignancies and life-threatening problems of benign thoracic diseases. Infection control, safety of patients & healthcare personnel remains the cornerstone. In this article we present our experience of Thoracic surgery during this pandemic. Our results & experience are similar to the guidelines & survey reports published by thoracic surgeons till date.
  - 2,036 210
Group III Pulmonary Hypertension: relative frequency of different etiologies in a referral pulmonary OPD
Parthasarathi Bhattacharyya, Sayoni Sengupta, Dipanjan Saha, Mintu Paul, Priyanka Choudhury, Sanjukta Dasgupta
July-December 2020, 8(2):69-75
Background: The prevalence of pulmonary hypertension (PH) in India remains unknown. The literature is scanty from the country regarding different types of PH. The etiological distribution of Group III PH in a pulmonologist’s practice, therefore, will be worthwhile to note. Method: We included patients with pulmonary hypertension following convenience sampling from those been diagnosed with PH in our pulmonary OPD services on the basis of a novel clinico-radio-echocardiographic criteria. They were then evaluated for the apparent and predominant underlying etiology. Patients with clear and defined diagnosis of COPD, asthma, DPLD, OSA and CTEPH were charted along with those having no obvious etiology but a history of treatment of tuberculosis in the past, along with a group marked as the “others” that consisted of a number of known (sarcoidosis, rheumatic heart disease, etc.) and some incompletely evaluated patients. Results: A total of 356 patients were recruited. The relative frequencies have been accounted to 35.81%, 20.66% and 13.77% for COPD, DPLD and asthma respectively. The patients with a history of TB without any other forthcoming etiology formed 12.67% of the group. The patients with OSA and CTEPH accounted for 2.75% of the group and the “Others” group occupied the rest 14.32%. Conclusion: Group III PH is found not infrequent in pulmonary practice and COPD tops the etiological list.
  - 1,550 124
A cross-sectional study on tobacco use prevalence and reasons for its use among male youth in a resettlement colony of Delhi
Vikas Yadav, Deepti Dabar
July-December 2020, 8(2):76-80
Introduction: It is estimated that 5,500 adolescents started using tobacco every day in India. The prevention of tobacco use in young Indians appears to be one of the largest opportunities for controlling this ever-growing epidemic. In India, like in other developing countries, the most susceptible time for initiation of tobacco is during youth, that is in the age group of 15–24 years. Material and Methods: This cross-sectional study was conducted in Kalyanpuri, a resettlement colony in New Delhi, India. The study included males aged 15–24 years residing in the study area at the time of survey. A semi-structured interview schedule was designed and translated into Hindi to elicit information on tobacco use. Results: Prevalence of tobacco use (ever user) was found to be 31.3%. Among ever users, 225 (27.7%) were current users and 9 (3.6%) were past users. Peer pressure (140, 62.2%) was found to be most common reason for initiation, whereas habit (143, 63.5%) of having tobacco was most common reason for continuation of tobacco use.
  - 1,484 109
Is chronic obstructive pulmonary disease under-diagnosed in patients with coronary artery disease? A tertiary care centre experience from central India
Kislay Kishore, Anubhuti Singh, M.S. Barthwal, Debjyoti Bhattacharyya, C.D.S. Katoch, Rahul Tyagi, Sandeep Rana
July-December 2020, 8(2):81-87
Context: Although worldwide studies are available regarding the prevalence of COPD in CAD patients, data from India are sparse. Aims: The purpose of this study was to determine the prevalence of undiagnosed and therefore, untreated COPD in patients suffering from CAD. It would also attempt to establish the need for screening of patients diagnosed with CAD for COPD. Settings and Design: A cross-sectional, observational study carried out at the respiratory out patients department (OPD) of a tertiary care centre of armed forces over a period of one year. Methods and Material: 79 patients with angiographically proven CAD underwent spirometry to assess the prevalence of COPD. Statistical Analysis Used: Data analysis was done using SPSS (Statistical Package for Social Sciences) version 21.0. Results: The mean age of the patients was 62.49 years (±8.77). Mean smoking index was 235.88. Nine patients (11.39 %) were diagnosed to have COPD. All the patients diagnosed as COPD were male, >60 years old and had normal BMI. 88.9 % patients with COPD were smokers. On comparing the patients with and without COPD, a significant co-relation was found with LVEF (%) (P = 0.044). 44.4% patients had never been diagnosed with COPD. Conclusions: The prevalence of missed diagnosis of COPD is significant in our study. We recommend that at the time of diagnosis of CAD, the initial evaluation should include a detailed history, clinical examination and evaluation of lung function by spirometry.
  - 1,326 118
Echocardiographic evaluation of stable chronic obstructive pulmonary disease (COPD) patients
Hemant Kumar, Ajay Kumar Verma, Anuj Kumar Pandey, Utkarsh Kumar Srivastava, Manoj Kumar Pandey, Rishabh Chaudhary, Surya Kant
July-December 2020, 8(2):88-91
Context: Chronic obstructive pulmonary disease (COPD) is the second leading cause of mortality in India, cardiovascular disease (CVD) comorbidity further increases morbidity and mortality of COPD. Early detection of CVD by echocardiography in COPD helps to reduce mortality and morbidity. Objective: We aimed to assess the echocardiographic findings in stable COPD patients. Materials and Methods: Patients with stable COPD, confirmed by spirometry, were recruited from the two tertiary care centre of India between August 2017 and August 2019. After thorough clinical examinations, patients have undergone echocardiography for CVD evaluation. Results: A total of 110 COPD patients were recruited, 91 male and 19 female. On echocardiographic evaluation, pulmonary arterial hypertension (PAH) was seen in 45.5% of COPD with mild, moderate, severe 14.5%, 11% and 20% respectively. Cor-pulmonale was seen in 9.1%. Left ventricular hypertrophy (LVH), left ventricular diastolic dysfunction (LVDD) and left ventricular systolic dysfunction (LVSD) was seen in 11%, 39.1% and 13.6% of COPD respectively. CVD involvement was more common in very severe COPD (40.1%). Conclusion: In this study, 78.2% of COPD have at least one form of CVD as co-morbidity. A simple, cheaper, non-invasive, widely an available investigation like echocardiography is useful to detect CVD at an early stage.
  - 1,473 157
Serum procalcitonin in predicting bacterial exacerbation of COPD and need for ventilatory support
Yogendra Rathore, Anshika Jindal, Vinod Joshi, Shubhra Jain, Shweta Bhati
July-December 2020, 8(2):92-98
Context: Acute exacerbation of COPD is very common disease and 20% of the COPD patients keep getting admitted with exacerbation. Serum procalcitonin (PCT) measurement is important to discriminate bacterial infection from other causes of AECOPD. Quick recognition along with prompt intervention may be the only action that prevents respiratory failure. Aims: To correlate serum PCT level with bacteriological profile and their need for ventilatory support in patients with AECOPD. Settings and Design: Hospital-based comparative type of cross-sectional study was conducted at the department of respiratory medicine in a tertiary care center of Rajasthan. Methods and Material: This comparative type of cross-sectional study was conducted between 45 AECOPD patients and 35 stable COPD patients. Serum PCT levels and sputum pyogenic culture were noted in all subjects. Statistical Analysis Used: Data collected were entered into excel spreadsheet and quantitative data were expressed as number and percentage. Results: There was a highly statistically significant difference of mean PCT value (P value < 0.003) between AECOPD patients (1.34 ± 2.53 ng/ml) and stable COPD patients (0.07 ± 0.05 ng/ml). Also, we found a statistically significant difference of mean PCT value (P value < 0.001) between AECOPD patients infected with Pseudomonas aeruginosa (3.64 ng/dl) and with other bacteria. A statistically significant difference (P value < 0.001) was present among AECOPD patients that needed invasive ventilation (5.41 ± 4.01 ng/ml), non-invasive ventilation (0.65 ± 0.81 ng/ml) and those did not need mechanical ventilation (0.27 ± 0.25 ng/ml) regarding the mean values of PCT. Conclusions: Our study found that higher PCT levels in severe AECOPD patients were associated more with bacterial infection and necessity of ventilatory support. Serum PCT can be used as good biomarker for intensive care unit admission.
  - 1,484 116
COVID 19-lung interactions: the salient points for pulmonologist
Arup Halder, Arpita Halder
July-December 2020, 8(2):39-41
The COVID 19 virus gains entry into body by docking to ACE2 receptors of lungs. Subsequently it deranges the balance in RAS and destabilizes oxidant-antioxidant systems. It leads to cytokine storm and endothelial dysfunction. Intially lung is compliant but patients may be hypoxic due to vasoplegia. Later typical full blown ARDS set in.
  - 2,265 276
Nintedanib for the treatment of idiopathic pulmonary fibrosis: An Indian perspective
Anubhuti Singh, Kislay Kishore, Ajay K Verma, Arpita Singh
July-December 2020, 8(2):48-52
Idiopathic pulmonary fibrosis (IPF) is a chronic disease associated with progressive deterioration of lung function and ultimately death. Until recent past, no drug therapy was approved for the management of IPF and patients either received symptomatic treatment or were enrolled in clinical trials. Since 2014, two new drugs with anti-fibrotic potential have been approved following positive outcomes in large-scale clinical trials. Nintedanib is the latest drug in this category and has recently been launched in India. Here we present a review about nintedanib, covering its mechanism of action, efficacy, adverse effect profile, cost effectiveness and implications in the Indian setting.
  - 2,578 214